Life Science Biosensor Diagnostics Pty Ltd, 10% Owner at GBS Inc. (GBS), sold 300,000 shares at $0.70 ($213K) on 2022-02-14, disclosed to the SEC on 2022-02-17.
Open-market sale of $213k GBS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.75 | 100,000 | $75K | 35.2% |
| 2 | $0.70 | 100,000 | $70K | 32.9% |
| 3 | $0.68 | 100,000 | $68K | 31.9% |
| Total | $0.71 avg | 300,000 | $213K | 100% |
| Filing → |
| GBS | SELL | 2022-02-15 | $84K | — | Filing → |
| GBS | SELL | 2022-02-11 | $86K | — | Filing → |
| GBS | SELL | 2022-02-10 | $89K | — | Filing → |